http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6365499

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 460
issn 0920-1211
issueIdentifier 3
pageRange 451-460
publicationName Epilepsy Research
startingPage 451
bibliographicCitation Christe W, Krämer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 1997 Mar;26(3):451–60. doi: 10.1016/s0920-1211(96)01013-3. PMID: 9127726.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a878ce5196487fbc29016a4e3e0ed07
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11b7a7f025efe69e99a12e93226b467c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff1b94b514c3c42bd6a9a972db48fb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_494245c1086712b0223a66cbb435446b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4af743e9754e83f29c3c152145c015c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4cecedc48acea399b408cd6291b9154
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ffa1a56d76ceb88754b6a644b4a6660
date 199702
identifier https://pubmed.ncbi.nlm.nih.gov/9127726
https://doi.org/10.1016/s0920-1211%2896%2901013-3
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0022501
http://id.nlm.nih.gov/mesh/M0003328
http://id.nlm.nih.gov/mesh/M0109945
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D014635Q000627
http://id.nlm.nih.gov/mesh/D002220Q000031
http://id.nlm.nih.gov/mesh/D004830Q000188
http://id.nlm.nih.gov/mesh/D004829Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002220Q000009
http://id.nlm.nih.gov/mesh/D000927Q000008
http://id.nlm.nih.gov/mesh/D002220Q000008
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D002220Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D000927Q000009
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D014635Q000009
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D014635Q000008
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D000078330
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34312

Total number of triples: 56.